Porphyria Cutanea Tarda – a Case Report
By: Tatjana Vukanović, Željko Mijušković, Lidija Kandolf-Sekulović, Lidija Zolotarevski and Radoš Zečević
Open Access
|Mar 2014References
- 1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet 2010;375:924-37.
- 2. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda-when skin meets liver. Best Pract Res Clin Gastroenterol 2010;24:735-45.
- 3. Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood 2012;120:4496-504.
- 4. Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E. Porphyrias at a glance: diagnosis and treatment. Intern Emerg Med 2010;5(Suppl 1):S73-S80.
- 5. Badenas C, To-Figueras J, Phillips JD, Warby CA, Munoz C, Herrero C. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin Genet 2009;75:346-53.
- 6. Bickers DR, Frank J. The porphyrias. In:Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill; 2007. p. 1228-56.
- 7. Waldenstrom J. Srudien uber porphyrie. Acta Med Scand 1937;82(Suppl):1-254.
- 8. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CS, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2000. p. 2991-3062.
- 9. Bickers DR, Frank J. The porphyrias. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, et al. eds. Dermatology in general medicine. 6th ed. New York: McGraw Hill; 2003. p. 1435-66.
- 10. de Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea: two different diseases. Hum Genet 1978;44:145-51.
- 11. Elder GH, Lee GB, Tovey JA. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 1978;299:274-8.
- 12. Felsher BF, Carpio NM, Engleking DW, Nunn AT. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda. New Engl J Med 1982;306:766-9.
- 13. Kushner J P, Barbuto AJ, Lee GR. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest 1976;58:1089-97.
- 14. Byrne JP, Boss JM, Dawber RP. Contaceptive pill-induced porphyria cutanea tarda presenting with onycholysis of the finger nail. Postgrad Med J 1976;52:535-8.
- 15. Taylor JS. Porphyria cutanea tarda symptomatica. Cutis 1970;6:1261-74.
- 16. Boffa MJ, Reed P, Weinkove C, Ead RD. Hypertrichosis as the presenting feature of porphyria cutanea tarda. Clin Exp Dermatol 1995; 20:62-4.
- 17. Kapoor R, Johnson RA. Porphyria cutanea tarda and hypertrichosis. N Engl J Med 2013;360(14):1356.
- 18. Cripps DJ, Peters HA, Gocmen A, Dogramici I. Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients. Br J Dermatol 1984;111:413-22.
- 19. Haberman HF, Rosenberg F, Menon IA. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens. Can Med Assoc J 1975;113:653-5.
- 20. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon- alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 1998;43:529-33.
- 21. Ashton RE, Hawk JL, Magnus IA. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol 1984;111:609-13.
- 22. Valls V, Ena J, Enriquez-De-Salamanca R. Low-dose oral chloroquine in patints with porphyria cutanea tarda and lowmoderate iron overload. J Dermatol Sci 1994;7:169-75.
- 23. Kordac V, Kotal JP, Kalab M. Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment. Semin Haematol 1989;26:16-23.
- 24. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 1979; 67:277-86.
- 25. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol 2001; 26:225-32.
- 26. Ghosh SK, Bandyopadhyay D, Chatterjee G, Ghosh AP. Porphyria cutanea tarda. J Assoc Physicians India 2008;56:441.
- 27. Christoph S, Huttmann A, Duhrsen U, Roth A. Porphyria cutanea tarda. Br J Haematol 2010;148:493.
- 28. Stolzel U, Kostler E, Schuppan D, Richter M, Wollina U, Doss MO, et al. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 2003;139:309-13.
DOI: https://doi.org/10.2478/sjdv-2013-0012 | Journal eISSN: 2406-0631
Language: English
Page range: 141 - 148
Published on: Mar 7, 2014
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2014 Tatjana Vukanović, Željko Mijušković, Lidija Kandolf-Sekulović, Lidija Zolotarevski, Radoš Zečević, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons License.